Apr 3, 2012

There is insufficient evidence to support or refute use of IVIg in the routine treatment of postpolio syndrome.

New AAN Guideline on IVIg in Neuromuscular Disorders.

March 26, 2012 — The American Academy of Neurology (AAN) has published an evidence-based guideline on the use of intravenous immunoglobulin (IVIg) in the treatment of neuromuscular disorders.

Developed by the Therapeutics and Technology Assessment Subcommittee of the AAN, the document, along with a 2-page summary for clinicians, is published in the March 27 issue of Neurology.

"Treatment with IVIg has increased and neurologists, and other clinicians who treat neuromuscular disease, should be aware of the data supporting its use," guideline lead author Huned S. Patwa, MD, from Yale University and the Veterans Affairs Connecticut Healthcare System, New Haven, told Medscape Medical News.

Continue reading www.medscape.com